All News

During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.

Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.

A new test may help direct treatments for patients with rare breast cancer mutations.

In June 2020, 56% of people over 50 years of age said they sometimes or often felt isolated from others, more than double the 27% who felt this way in a similar poll in 2018.

This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency department (ED) of a hospital.

The CINtec PLUS Cytology assay is indicated for women who undergo cervical cancer screening and test positive for high-risk types of human papillomavirus.

The Cuprimine brand and generic market had US sales of approximately $80 million for the most recent 12 months ending in June 2020.

First-of-its-kind consortium made up of health care industry leaders aims to establish standards for RFID use.

The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.

The 2019 survey results from the Monitoring the Future (MTF) study showed that vaping marijuana and nicotine rose sharply in the past 3 years among college age students, or students between 19 and 22 years of age.

Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.

A study of Chinese women found COVID-19 heightened stress, fear, and depression during pregnancy.

Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.

Magrolimab is a first-in-class, investigational anti-CD47 monoclonal antibody used in combination with azacitidine in treatment-naïve patients with high and very high-risk myelodysplastic syndrome,

Dr. Reddy’s Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, is available as 7.5 mL fill in a 10 mL bottle.

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

Annual campaign encourages patients, colleagues, friends and family to recognize dedicated pharmacy professionals through social media.

Most notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.

The types of SUDs investigated were tobacco, alcohol, opioid, cannabis, and cocaine.

It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.

The Mediterranean diet has shown efficacy in preventing several noncommunicable diseases.

Although the presence of rhinovirus limited the ability of influenza to infect cells, researchers do not know whether the same effect will be seen with COVID-19.

An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.

The FDA grants fast track designation to the highly-selective N-terminal domain inhibitor EPI-7386 for the treatment of adult patients with metastatic castration-resistant prostate cancer.

Bristol Myers Squibb announced it will present data from research spanning 15 different cancers with high unmet need at the ESMO Virtual Congress 2020.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Levodopa may reduce the need for painful injections in patients with age-related macular degeneration.

Two phase 3 studies showed an investigational 15-valent pneumococcal conjugate vaccine (V114, Merck) was well-tolerated among patients and met the primary immunogenicity objectives.

Figuring out how to target vulnerable cells in breast cancer tumors can help treat the disease more effectively.

Study results provide an opportunity for pharmacists to ensure their patients are on an appropriate dosage or to council on alternatives for older adults at risk of cognitive decline.